Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Ecphora Capital is a venture capital firm located in Baltimore, Maryland, that concentrates on the medical technology sector. Founded by Deborah Hemingway, Ph.D., the firm aims to support medtech startups through a structured, data-driven program. Established in a region known for its biotech innovation, Ecphora leverages its proximity to leading medical and research institutions to identify and nurture promising ventures.
The firm emphasizes the Maryland-DC-Virginia area as a hub for healthcare innovation, providing a strategic advantage for startups in the medical technology space. Ecphora Capital is committed to enhancing patient outcomes and transforming healthcare systems through its investments. The firm currently operates with a focus on pre-seed, seed, and Series A funding stages, although specific metrics regarding fund size or portfolio count are not disclosed.
Ecphora Capital invests in a variety of sectors within the healthcare industry, including medical devices, biotechnology, digital health, and healthtech. The firm specifically targets startups that leverage innovative solutions to improve patient treatment and healthcare systems. Their investment strategy includes a proprietary startup program that evaluates companies based on critical success parameters over a three-month period, ensuring that they are well-positioned for growth and impact.
Investment stages include pre-seed, seed, and Series A, allowing Ecphora to engage with companies at various points in their development. The firm seeks to partner with founders who demonstrate a strong vision and the ability to execute on their ideas. Geographic focus is primarily on North America, particularly within the United States, where the firm can capitalize on its established connections and resources.
Ecphora Capital has formed strategic partnerships with several prominent organizations that enhance its access to early-stage companies in the medtech sector. Notable partnerships include:
These partnerships not only provide access to promising startups but also foster innovation within the medical technology sector.
Deborah Hemingway: Managing Partner. Deborah has extensive experience in the medical technology sector and has led numerous successful investments in healthcare startups.
Jeremy Neilson: Managing Director, Head of Operations. Jeremy oversees the operational aspects of the firm and has a background in managing healthcare ventures.
Charles Kirby: Venture Partner. Charles brings expertise in biotech investments and has a history of working with early-stage companies.
Sathya Janardhanan: Venture Partner. Sathya specializes in digital health and has a strong track record in scaling healthcare startups.
Lauren Renz: Director of Investor Relations. Lauren manages relationships with investors and has experience in fundraising for healthcare ventures.
Cayden Johnson: Capital Campaign Strategist. Cayden focuses on capital raising strategies and has a background in venture capital.
Nick Stewart: General Counsel. Nick provides legal guidance and has experience in healthcare regulations.
Joel Ruffini: Special Counsel. Joel supports the firm with legal matters related to investments.
Aiza Torres: Executive Assistant. Aiza assists with administrative tasks and supports the team in daily operations.
Tom Coale: Government Relations. Tom works on building relationships with government entities and stakeholders in the healthcare sector.
To pitch Ecphora Capital, founders should submit their proposals through the firm's website or via email at admin@ecphoracapital.com. A well-structured pitch deck is essential, including details about the startup's mission, market opportunity, product development stage, and financial projections. The firm prefers to receive pitches that include a clear outline of the team’s expertise and experience in the healthcare sector.
Response times can vary, but founders can expect to hear back within a few weeks. Warm introductions are beneficial, especially from mutual connections within the healthcare or venture capital space, as they can enhance the likelihood of a favorable review.
Ecphora Capital runs a proprietary startup program that evaluates early-stage medtech companies over a three-month period. This program focuses on assessing critical success parameters to ensure that startups are well-positioned for growth and impact in the healthcare sector. Startups interested in participating can apply through the firm's website.
As of October 2023, Ecphora Capital has been actively engaging with the medtech ecosystem through its strategic partnerships with organizations such as The LaunchPort and Johns Hopkins University. These collaborations aim to foster innovation and provide access to early-stage companies in the healthcare sector.
Additionally, the firm continues to refine its proprietary startup program, which assesses critical success parameters for medtech startups over a three-month period. This program is designed to enhance the potential for successful outcomes in the healthcare technology space.
What are Ecphora Capital's investment criteria?
Ecphora Capital focuses on startups in the medical technology sector, particularly in healthcare, biotech, digital health, and medical devices. They look for innovative solutions that can enhance patient treatment and healthcare systems.
How can I apply or pitch to Ecphora Capital?
Founders can pitch their startups by visiting the Ecphora Capital website at ecphoracapital.com or by emailing admin@ecphoracapital.com. A structured pitch deck that outlines the business model, market opportunity, and team is recommended.
What makes Ecphora Capital different from other investors?
Ecphora Capital employs a proprietary three-month startup program that assesses critical success parameters for medtech startups. This structured approach helps ensure that investments are made in companies with strong potential for growth and impact.
What is the geographic scope of Ecphora Capital's investments?
The firm primarily focuses on North America, specifically the United States, leveraging its connections in the Maryland-DC-Virginia region.
What is the typical check size for investments?
While specific check sizes are not disclosed, Ecphora Capital invests in pre-seed, seed, and Series A stages, which typically range from hundreds of thousands to several million dollars.
What kind of post-investment involvement does Ecphora Capital have?
Ecphora Capital actively engages with its portfolio companies through mentorship, operational support, and access to its extensive network of partners and resources in the healthcare sector.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.